Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone and laser for diabetic macular oedema
NCT00148265Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Apr 2005
- Primary completion
- May 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone in diabetic macular edema (DME), sponsored by University of Sydney. Started Apr 2005; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00148265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148265.